2 results
Approved WMOCompleted
Primary Objectives* Compare OS in NSCLC patients with adenocarcinoma histology treated with ganetespib in combination with docetaxel versus docetaxel aloneSecondary Objectives* Compare progression-free survival (PFS) between the 2 treatment arms*…
Not approvedWill not start
To compare the EPOS guideline with the free choice treatment of the GP for acute rhinosinusitis in general practice.